Detalhe da pesquisa
1.
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice.
Mol Ther
; 32(3): 722-733, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311852